Allogeneic Sibling and Unrelated Donor Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Busulfan, Etoposide and Cyclophosphamide
To learn whether a new preparative regimen to prepare patients for bone marrow
transplantation is useful in patients above 50 years of age and whether it is useful in
patients with myelodysplastic syndromes.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Robert S Negrin
United States: Institutional Review Board
|Stanford University School of Medicine||Stanford, California 94305-5317|